REFERENCES
- Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495–7.
- Kohler G, Milstein C. Derivation of specific antibody-produc-ing tissue culture and tumor lines by cell fusion. Eur J Immunol 1976; 6: 511–9.
- Silverberg E, Lubera JA. Cancer statistics, 1989. CA Cancer J Clin 1989; 39: 3–20.
- Tolley DA, Hargreave TB, Smith PH, et al. Effect of intraves-ical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). Br Med J Clin Res Ed 1988; 296: 1759–61.
- Tolley DA, Parmar MK, Grigor KM, et al. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol 1996; 155: 1233–8.
- Silverberg E, Boring CC, Squires TS. Cancer statistics, 1990. CA Cancer J Clin 1990; 40: 9–26.
- Raghavan D, Shipley WU, Garnick MB, Russell PJ, Richie JP. Biology and management of bladder cancer. N Engl J Med 1990; 322: 1129–38.
- Heney NM, Nocks BN, Daly JJ, et al. Ta and Ti bladder cancer: location, recurrence and progression. Br J Urol 1982; 54: 152–7.
- Taylor-Papadimitriou J, Peterson JA, Arklie J, Burchell J, Ceriani RL, Bodmer WF. Monoclonal antibodies to epithe-1Mm-specific components of the human milk fat globule mem-brane: production and reaction with cells in culture. Int J Cancer 1981; 28: 17–21.
- Conn IG, Crocker J, Emtage LA, Wallace DMA. HMFG2 as a prognostic indicator in superficial bladder cancer. J Clin Pathol 1991; 41: 1191–5.
- Arklie J, Taylor-Papadimitriou J, Bodmer W, Egan M, Millis R. Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers. Int .1-Cancer 1981; 28: 23–9.
- Burchell J, Durbin H, Taylor-Papadimitriou J. Complexity of expression of antigenic determinants, recognized by mono-clonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells. J Immunol 1983; 131: 508–13.
- Fraker PJ, Speck JC Jr. Protein and cell membrane iodina-tions with a sparingly soluble chloroamide, 1,3,4,6-tetra-chloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun 1978; 80: 849–57.
- Syrigos KN, Epenetos AA. Radioimmunotherapy of ovarian cancer. Hybridoma 1995; 14: 121–4.
- Kunkler RB, Bishop MC, Green DJ, Pimm MV, Price MR, Frier M. Targeting of bladder cancer with monoclonal anti-body NCRC48-a possible approach for intravesical therapy. Br J Urol 1995; 76: 81–6.
- Bamias A, Bowles MJ, Krausz T, Williams G, Epenetos AA. Intravesical administration of indium-111-labelled HMFG2 monoclonal antibody in superficial bladder carcinomas. Int .1-Cancer 1993; 54: 899–903.
- Bamias A, Keane P, Krausz T, Williams G, Epenetos AA. Intravesical administration of radiolabeled antitumor mono-clonal antibody in bladder carcinoma. Cancer Res 1991; 51: 724–8.
- Li L, Zhang Y, Lin Q, Li C, He M. Clinical application of monoclonal antibody-drug conjugate to immunotargeting chemotherapy of bladder cancer. Chin Med J Engl 1995; 108: 764–8.
- Syrigos KN, Rowlinson-Busza G, Epenetos AA. In vitro cytotoxicity following specific activation of amygdalin by 13-glucosidase conjugated to a bladder cancer-associated mon-oclonal antibody. Int .1- Cancer (in press).